NCT06101290View on ClinicalTrials.gov

Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 5, 2023

Primary Completion Date

December 5, 2025

Study Completion Date

January 5, 2031

Conditions
Prostate CancerOligoprogressiveUrothelial CarcinomaRenal Cell Carcinoma
Interventions
DEVICE

Ablative local therapy

Stereotactic ablative radiotherapy (SABR) or interventional radiology (IR) ablation therapy

Trial Locations (1)

95817

RECRUITING

University of California, Davis, Sacramento

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, Davis

OTHER